Goodwin represented longtime client Imprivata (NYSE: IMPR) in its announced definitive agreement through which the healthcare IT security company will be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm. The transaction is valued at approximately $544 million.
Founded in 2002 and headquartered in Lexington, MA, Imprivata enables healthcare organizations globally to access, communicate, and transact patient information securely and conveniently. The Imprivata platform addresses critical compliance and security challenges while improving productivity and the patient experience.
Thoma Bravo is a leading private equity investment firm with a 30+ year history of providing equity and strategic support to experienced management teams and growing companies. It invests with a particular focus on application and infrastructure software and technology enabled services, and currently manages a series of private equity funds representing more than $17 billion of equity commitments.
The Goodwin team advising Imprivata was led by partners Kenneth Gordon, Joseph Johnson III and Andrew Goodman (Technology & Life Sciences).
For more information on the transaction, please view Imprivata and Thoma Bravo’s joint press release.